Proficio Capital Partners LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Proficio Capital Partners LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,633 shares of the financial services provider’s stock, valued at approximately $480,000.

A number of other large investors have also added to or reduced their stakes in IBB. BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $18,476,000. DRW Securities LLC bought a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $5,678,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $135.31 on Tuesday. The company’s 50 day moving average price is $136.25 and its 200-day moving average price is $139.23. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The company has a market capitalization of $6.39 billion, a P/E ratio of 27.83 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.